Keros Therapeutics, Inc. - stock earnings
KROS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -40.2 million USD | 143000 USD |
| 2023Q3 | -39.4 million USD | 8000 USD |
| 2023Q2 | -37.5 million USD | ? USD |
| 2023Q1 | -32.7 million USD | ? USD |
| 2022Q4 | -29.7 million USD | ? USD |
| 2022Q3 | -19.0 million USD | ? USD |
| 2022Q2 | -23.8 million USD | 100000 USD |
| 2022Q1 | -24.2 million USD | ? USD |
| 2021Q4 | -6.9 million USD | 20.0 million USD |
| 2021Q3 | -20.3 million USD | ? USD |
| 2021Q2 | -15.6 million USD | 100000 USD |
| 2021Q1 | -15.9 million USD | ? USD |
| 2020Q4 | -10.7 million USD | ? USD |
| 2020Q3 | -12.0 million USD | 2.5 million USD |
| 2020Q2 | -10.8 million USD | 2.5 million USD |
| 2020Q1 | -11.9 million USD | 2.5 million USD |
| 2019Q4 | -2.8 million USD | 2.5 million USD |
| 2019Q3 | -3.5 million USD | 2.5 million USD |
| 2019Q2 | -2.9 million USD | 2.5 million USD |
| 2019Q1 | -3.2 million USD | 2.5 million USD |
KROS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -153.0 million USD | 151000 USD |
| 2022 | -104.7 million USD | 20.0 million USD |
| 2021 | -58.7 million USD | 20.1 million USD |
| 2020 | -45.4 million USD | 2.5 million USD |
| 2019 | -12.3 million USD | 10.0 million USD |
| 2018 | -1.3 million USD | 10.0 million USD |
KROS
Price: $57.72
52 week price:
Earnings Per Share: -5.20 USD
P/E Ratio: -11.92
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 412500
Market Capitalization: 2.1 billion